
Screening mammography can improve triple-negative breast cancer survival rates for African-American women.

Screening mammography can improve triple-negative breast cancer survival rates for African-American women.

Volpara Solutions Chief Knowledge Officer Julian Marshall talks with Diagnostic Imaging about the impetus and impact of the partnership with ScreenPoint Medical

Research indicates breast density laws aren't working well, and online patient education resources likely aren't helping.

The latest roundup of radiology news and studies.

How-to guidance for using abbreviated MRI as a screening tool.

The trends and technologies driving mammography in 2019 and beyond.

From the efficacy of AI as a cyberweapon to MRI for diagnosing strokes, the latest radiology news and studies you need to know.

From updated mammography screening guidelines to a link between obesity and brain structure, these are the studies and news you need to know.

Women who participated in regular breast screening programs benefitted more from therapy than women who were not screened regularly.

Lobular or HER2–negative cancers are underestimated in size at MRI compared with ductal or other subtypes.

Some were concerned about increased imaging and interpretation times associated with DBT.

Not following ACR practice guidelines potentially leads to unnecessary workups and extra health care costs.

Algorithm may help better predict how likely it is a woman will have cancer in her future.

The problem of density and what it has meant for radiologists.

The two screening methods have similar sensitivity and specificity in finding microcalcifications.

Tomosynthesis plus breast volume scanner could be replacement for breast cancer staging if MRI cannot be performed.

Most states require at least some women to receive information about breast density-and that information is leading to more conversations.

Breast radiologists will need an algorithm for addressing the small number of inconclusive findings that remain equivocal.

MRI after 12 weeks of therapy predicts complete pathologic response to neoadjuvant chemotherapy.

Screening at age 40 detects more stage 1 breast cancers.

More research needed to evaluate the role of communication in completing the breast cancer screening episode.

The use of synthesized mammography instead of additional full-field digital mammography has no significant effect on biopsy rate.

Interventions targeting radiologist factors may help reduce unwarranted variation in screening recalls.

A total of 35 percent of cancers diagnosed after second-opinion review were not initially detected in the original interpretation.

Further study may determine if patient awareness can mitigate the underutilization of supplemental screening breast MRI.